Planaletix was founded with the initial goal of creating an automated business decision platform, later expanding to an ecosystem merging AI, genomics, and blockchain.

The Genaty.ai platform began accepting the $PLTX token for the purchase of DNA analysis packages.

Planaletix announced that 5% of Genaty.ai's monthly revenue would be added to the $PLTX liquidity pool for 12 months.

Planaletix announced its application was approved for the $PLTX token to be listed on the MEXC crypto exchange.